Aerobic Exercise and Chronic Pain

What aerobic exercise is

Aerobic exercise is continuous, rhythmic activity involving large muscle groups, sustained for prolonged periods and performed at an intensity that allows oxidative metabolism to meet energy demand. Clinically, it is defined by the intensity range of 40 to 75% of VO2 max — peak oxygen consumption during progressive effort. In this window, heart rate rises, ventilation grows proportionally to consumption, and the patient can, in principle, sustain activity for 20 to 60 minutes without interruption.

Classic examples include brisk walking, stationary or outdoor cycling, elliptical, swimming, dance, rowing, light running, and water aerobics. The choice between modalities is pragmatic: it depends on patient preference, joint limitations (swimming and cycling spare the knee; walking is universally accessible), equipment availability, and routine. In chronic pain, adherence is usually more important than the ideal modality — 150 weekly minutes of walking that the patient actually does outperform 150 minutes of running that they abandon in two weeks.

It is important to differentiate continuous aerobic from HIIT (High Intensity Interval Training) — a separate protocol, with short intervals of high intensity alternated with recovery periods, whose specific discussion is in a dedicated article. Traditional aerobic, the focus of this text, operates at sustained moderate intensity; HIIT, in interspersed peaks of vigorous intensity. Central mechanisms partially overlap, but prescription, initial tolerance, and safety profile are distinct.

Aerobic intensity can be measured by four complementary metrics. Percentage of VO2 max is the most precise physiologic parameter, but requires ergospirometric testing for individual calibration. Heart rate, expressed as a percentage of maximum HR (220 minus age, as approximation), is the most practical day-to-day metric — the 50-70% HRmax range corresponds, on average, to moderate intensity. The Borg scale (RPE 6-20) is a simple clinical instrument: values 11-14 ("light" to "somewhat hard") cover the moderate range. Finally, the talk test is the most accessible parameter: at moderate intensity, the patient can speak full sentences but cannot sing; at vigorous intensity, only short sentences; if they cannot speak, intensity is too high.

Mechanism of action

The effect of aerobic exercise on chronic pain is not local and, in most conditions, does not depend on structural change in the painful tissue — it is a central and systemic effect, mediated by mechanisms that converge on circuits involved both in pain processing and in regulation of mood, sleep, and stress response. This convergence is what explains why aerobic has particularly strong impact in nociplastic conditions, such as fibromyalgia, and in conditions where pain, depression, anxiety, and insomnia feed each other.

The most studied mechanism is the sustained increase of BDNF (brain-derived neurotrophic factor) and the stimulation of hippocampal neurogenesis. Regular aerobic exercise induces BDNF expression in multiple brain regions, with special relevance in the hippocampus — an area involved in memory, emotional regulation, and, as the neuroscience of pain has been demonstrating in the last two decades, in components of persistent pain processing. The synaptic plasticity that accompanies this increase is part of the biologic basis for the combined antidepressant and analgesic effect.

In parallel, aerobic modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing the chronically elevated baseline cortisol that characterizes patients with chronic pain associated with persistent stress. Progressive normalization of this axis has clinical consequences: it improves sleep architecture, reduces emotional reactivity to painful signals, and, over weeks to months, contributes to the reduction of central sensitization.

The release of endorphins, enkephalins, and serotonin during and after the aerobic session participates in acute analgesic effect and also in the subjective sense of well-being consistently reported in adherent patients. This opioidergic and monoaminergic arm is part of a broader phenomenon — exercise-induced hypoalgesia (EIH) —, which aerobic shares with other exercise modalities, although with a distinct temporal profile (more diffuse and sustained effect in continuous aerobic, more acute and localized in isometric regimens).

For nociplastic pain — the category for which fibromyalgia is the prototypical example — there is consistent evidence that aerobic reduces central sensitization. Psychophysical measures such as temporal summation and wind-up are attenuated after structured aerobic programs of 8 to 12 weeks, suggesting modulation of nociceptive processing in the dorsal horn of the spinal cord and in supraspinal circuits.

Two additional, frequently undervalued effects complete the picture. Aerobic improves sleep architecture — increases the proportion of slow-wave sleep, reduces sleep onset latency, and decreases nighttime awakenings — and sleep, by itself, is a strong variable for chronic pain control. Patients who sleep better report less pain even when the underlying nociceptive picture has not changed. And aerobic has a sustained systemic anti-inflammatory effect: it reduces baseline IL-6, raises IL-10, and attenuates markers of low-grade inflammation frequently present in patients with chronic pain and prolonged sedentarism.

The sum of these mechanisms is what justifies positioning aerobic as a central — not adjunctive — intervention in nociplastic pain. No single arm in isolation explains the clinical effect; their integration is what sets aerobic apart from symptomatic analgesics and conceptually aligns it with interventions that act on the central nervous system as a whole.

Scientific evidence

Aerobic exercise is, paradoxically, one of the treatments with the best evidence in chronic pain — and one of the most underprescribed. The literature has accumulated two decades of clinical trials, Cochrane systematic reviews, and international society guidelines pointing to aerobic as a first-line intervention in high-prevalence conditions such as fibromyalgia and chronic low back pain. In clinical practice, the gap between recommendation and prescription is significant — partly due to patient difficulty in adhering, partly due to medical undervaluation of the modality as "real treatment."

The central reference in fibromyalgia is the Cochrane systematic review by Busch et al. (2017), which consolidated trials of aerobic exercise in the condition. The conclusion was clear: aerobic produces significant pain reduction, improvement in fatigue, physical function, and overall well-being, with moderate to high quality evidence. This review provided the empirical basis for the EULAR 2017 guidelines (Macfarlane et al., Ann Rheum Dis 2017) to position aerobic exercise as a strong recommendation (grade A) first-line in fibromyalgia — above any isolated pharmacologic intervention in terms of strength of recommendation.

For chronic low back pain, the Cochrane review by Hayden et al. (2021) is the contemporary reference: exercise, with relevant aerobic component, reduces pain and improves function comparable to or superior to passive interventions and many pharmacologic treatments. Aerobic, alone or combined with strengthening, integrates first-line recommendations in major international guidelines for chronic low back pain.

In depression associated with pain, the meta-analysis by Schuch et al. consolidated aerobic as an intervention with clinically relevant antidepressant effect, comparable in magnitude to antidepressant drugs in mild to moderate cases. When depression coexists with chronic pain — common scenario in fibromyalgia, persistent low back pain, and patients with multiple pains —, the combined effect of aerobic on mood and pain is particularly valuable, since it addresses two clinical targets with a single intervention.

The Cochrane umbrella review by Geneen et al. (2017) — review of systematic reviews — consolidated exercise (with aerobic as the central component) as an effective intervention in multiple chronic pain conditions: fibromyalgia, low back pain, osteoarthritis, neck pain, and chronic pelvic pain. Heterogeneity between studies prevents estimating a single universal effect, but the direction and consistency of benefit are clear.

The widely adopted population target comes from the WHO 2020 Physical Activity Guidelines: 150 weekly minutes of moderate aerobic (or 75 minutes of vigorous, or equivalent combination) in adults, with distribution throughout the week. This is the population parameter — not individual —, and serves as a horizon for patients with chronic pain. In practice, deconditioned patients with pain start well below this target and reach it over 6 to 12 weeks, with gradual progression.

Prescription and dosing (FITT-VP)

Aerobic prescription follows the FITT-VP principle — Frequency, Intensity, Time, Type, Volume, and Progression. In chronic pain, adapting these parameters to the patient's state is more important than rapidly reaching any population target. Deconditioned patients with pain frequently start well below what seems clinically "sufficient" and reach the target of 150 weekly minutes only after 6 to 12 weeks of controlled progression.

Clinical principle: start low, go slow

The most common error in aerobic prescription for chronic pain is ambitious initial dose. Sedentary patients with fibromyalgia or chronic low back pain frequently start with 5 minutes of light walking, twice a week — a dose that, in healthy populations, would be considered insufficient. In these patients, this initial dose is therapeutic in two senses: it is physiologically safe and allows the experience of success that builds adherence. Subsequent progression is biweekly, not weekly, and clinical reassessments follow the patient's pace, not an idealized schedule.

The initial intensity should allow comfortable conversation — positive talk test, without significant breathlessness. If the patient can only speak in short sentences, intensity is already too high for an activity reintroduction phase. Borg 11-12 ("light") in the first 2-4 weeks, progressing to 13-14 ("somewhat hard") according to tolerance, is reasonable calibration.

In modality choice, patient preference weighs more than the "ideal" protocol. Walking is universally accessible, requires no equipment, and has zero cost — generally the starting point. Cycling or elliptical are appropriate choices when there is joint limitation in knee, hip, or ankle. Swimming and water aerobics offer total joint unloading and are particularly useful in severe osteoarthritis or in painful conditions with significant mechanical component. Any combination is acceptable — the principle is that the patient enjoys it enough to maintain.

Indications

Aerobic indications in chronic pain reflect the evidence profile: strong in nociplastic conditions and those with a relevant central component, supporting role in predominantly mechanical and joint conditions, and particularly important in patients with pain associated with depression, anxiety, or sleep disorders. Sedentarism amplifies all potential benefits — and is itself a factor that worsens chronic pain prognosis when left unaddressed.

How it is done

The aerobic plan in chronic pain is structured in phases, typically over 12 weeks to reach the weekly target, with periodic clinical reassessments and a gradual transition to a sustainable long-term program. Adherence is the main challenge: follow-up studies show maintenance rates of 60-70% at 3 months with supervision, falling to 30-40% at 12 months without structure — which shapes how the program is built from the start, with specific concern for sustainability.

Adherence is the main clinical challenge — and the literature on health behavior converges on a practical principle: preference outweighs fidelity to the ideal protocol. Recommending activity that the patient enjoys, even if not theoretically optimal, produces clinical results superior to prescribing the "correct" activity that will be abandoned in two weeks. Walking in a nearby park, cycling with company, group dancing, community water aerobics — any combination that integrates into the routine and brings some satisfaction has an advantage over isolated and solitary options.

Structured monitoring helps sustain adherence: wearable (activity watch or band) recording daily steps and heart rate, simple exercise diary (date, duration, perceived intensity, pre- and post-pain), or physical activity app. Clinical follow-ups with review of these data — instead of vague questions about "how is the exercise going" — make adherence visible and reinforce patient engagement in the process.

Risks and contraindications

Aerobic has a favorable safety profile when well indicated and the progression is properly calibrated. The central concern is prior cardiovascular screening in patients with risk factors — prescription is not blind, and early identification of absolute and relative contraindications reduces significant adverse events. Expected program effects (initial DOMS, adaptive fatigue, temporary pain exacerbation) need to be differentiated from signs of inadequate progression or acute cardiovascular event.

Expected program effects

Three situations are considered part of the expected course in the first weeks and should not be interpreted as failure or contraindication. Mild initial DOMS — delayed-onset muscle soreness, appears 24-72 hours after sessions of new load — reflects physiologic muscle adaptation and tends to decrease with program continuity. Adaptive fatigue in the first 1-2 weeks is an expected response to the new metabolic stimulus and dissipates as the cardiovascular and muscular system adapts.

Temporary pain exacerbation in 10-20% of patients in the first 14 days is the most critical effect to anticipate — especially in fibromyalgia. Patients informed in advance that this can occur, that it usually passes with adjusted progression, and that it does not indicate structural worsening of the condition tolerate this phase and continue in the program. Uninformed patients interpret the exacerbation as confirmation that "exercise worsens pain," abandon the intervention, and definitively label it as inappropriate for them. This initial conversation is part of the prescription.

What distinguishes an expected effect from a warning sign is persistence and pattern. Pain that grows for 3-4 weeks without stabilizing, new cardiovascular symptoms (angina, disproportionate dyspnea, syncope), new functional loss, or localized orthopedic pain with a clear mechanical pattern demand reassessment — usually a dose adjustment, but in some cases additional investigation.

Limitations and what is still not known

Despite consistent evidence and first-line positioning in multiple conditions, aerobic has practical limitations and known gaps that guide realistic use — avoiding both undue enthusiasm ("aerobic makes chronic pain disappear") and traditional skepticism that undervalues it.

Gaps and practical challenges

Adherence drops drastically after the supervised phase. Health behavior studies show a consistent pattern: 60-70% of patients stick with the program at 3 months when supervision or clinical structure is in place; this rate falls to 30-40% at 12 months once supervision ends and the patient is on their own. This is the main operational problem of aerobic as a long-term treatment — not a problem of biologic efficacy, but of behavioral sustenance. Strategies such as walking groups, monitoring apps, periodic reassessments, and integration into social routine help, but do not eliminate the issue.

Imprecise individual dose-response. The WHO target of 150 weekly minutes is population-based — built on cardiovascular health data and population outcomes — and is not necessarily the optimal individual dose for chronic pain. Some patients gain significant benefit from 90 well-distributed weekly minutes; others need greater volume for a clinical response; to date, no biomarker or clinical instrument precisely guides this individual calibration. Practice is empirical, with periodic reassessment.

Heterogeneous response and non-responders. Approximately 20% of patients with fibromyalgia do not respond clinically to aerobic even when adherence is adequate — phenomenon observed in different trials and reviews. Current literature has not identified robust clinical predictors that allow anticipating this subgroup before starting treatment. In non-responders after 12-16 weeks of well-executed program, the approach is to reassess the diagnosis, consider non-addressed comorbidities (major depression, untreated sleep disorder, associated neuropathic pain), and integrate other modalities — not simply increase aerobic volume.

Regression to the mean in small RCTs. Part of the literature on aerobic in chronic pain comes from trials with modest samples, in which regression to the mean can inflate effect estimates. Robust meta-analyses (Cochrane) mitigate this bias by pooling multiple studies, but heterogeneity between protocols (intensity, duration, modality) is real and prevents a single universal estimate. The direction of benefit is consistent; the exact magnitude for a specific patient is less precise than point estimates suggest.

Relationship with medical acupuncture

Aerobic and medical acupuncture share central neuromodulation mechanisms — activation of opioidergic pathways, descending pain modulation, effect on emotional regulation circuits and HPA axis —, but operate on distinct time scales and clinical profiles. Aerobic builds effect over weeks and sustains it as long as there is maintenance; acupuncture has effect per session of hours to days and accumulates over a structured cycle of weeks. This window difference is what makes the two modalities complementary in nociplastic chronic pain.

The synergy between the two modalities is particularly strong in the first weeks of an aerobic program in patients with significant pain. Acupuncture reduces acute pain enough to allow the patient to tolerate the start of exercise — the first-week barrier, in which baseline pain plus initial exacerbation frequently leads to dropout. One or two weekly acupuncture sessions as analgesic support in this phase can make the difference between an adhered program and one abandoned on the third day.

In a longer horizon, the division of roles usually follows the profile of each intervention: aerobic sustains central benefit in the medium and long term — it is what, over 12 to 16 weeks, consolidates reduction of central sensitization, mood improvement, and general reconditioning. Acupuncture can be maintained as a weekly or biweekly maintenance program in responding patients, particularly useful in moments of exacerbation, in transition periods (dose changes, interruptions due to intercurrent illness, resumption after a pause). This stratification by function — aerobic as continuous base, acupuncture as targeted modulation — is what allows integrating the two without redundant overlap.

When to seek medical help

The decision to start an aerobic program in chronic pain should go through medical evaluation — both to confirm the diagnosis and exclude alternative causes, and to calibrate the protocol to comorbidities and cardiovascular status. In patients with risk factors, prior screening reduces adverse events and identifies the subgroup that needs specific cardiologic evaluation before vigorous intensity.